An adverse outcome pathway for small intestinal tumors in mice involving chronic cytotoxicity and regenerative hyperplasia: a case study with hexavalent chromium, captan, and folpet.
Saved in:
| Title: | An adverse outcome pathway for small intestinal tumors in mice involving chronic cytotoxicity and regenerative hyperplasia: a case study with hexavalent chromium, captan, and folpet. |
|---|---|
| Authors: | Bhat VS; ToxStrategies, Inc., Hudson, MA, USA., Cohen SM; Havlik-Wall Professor of Oncology, Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA., Gordon EB; Elliot Gordon Consulting, LLC, Princeton Junction, NJ, USA., Wood CE; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA., Cullen JM; North Carolina State University, Raleigh, NC, USA.; EPL, Inc., Sterling, VA, USA., Harris MA; ToxStrategies, Inc., Katy, TX, USA., Proctor DM; ToxStrategies, Inc., Mission Viejo, CA, USA., Thompson CM; ToxStrategies, Inc., Katy, TX, USA. |
| Source: | Critical reviews in toxicology [Crit Rev Toxicol] 2020 Sep; Vol. 50 (8), pp. 685-706. Date of Electronic Publication: 2020 Nov 04. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 8914275 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1547-6898 (Electronic) Linking ISSN: 10408444 NLM ISO Abbreviation: Crit Rev Toxicol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1547-6898 |
|---|---|
| DOI: | 10.1080/10408444.2020.1823934 |
